Search by Drug Name or NDC
NDC 71143-0375-98 XHANCE 93 ug/1 Details
XHANCE 93 ug/1
XHANCE is a NASAL SPRAY, METERED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by OptiNose US, Inc.. The primary component is FLUTICASONE PROPIONATE.
MedlinePlus Drug Summary
Nonprescription fluticasone nasal spray (Flonase Allergy) is used to relieve symptoms of rhinitis such as sneezing and a runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies (caused by an allergy to pollen, mold, dust, or pets). Prescription fluticasone is also used to relieve symptoms of nonallergic rhinitis such as sneezing and runny or stuffy nose which are not caused by allergies. Prescription fluticasone nasal spray (Xhance) is used to treat nasal polyps (swelling of the lining of the nose). Fluticasone nasal spray should not be used to treat symptoms (e.g., sneezing, stuffy, runny, itchy nose) caused by the common cold. Fluticasone is in a class of medications called corticosteroids. It works by blocking the release of certain natural substances that cause allergy symptoms.
Related Packages: 71143-0375-98Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Fluticasone Nasal Spray
Product Information
| NDC | 71143-0375 |
|---|---|
| Product ID | 71143-375_c6843202-6ad2-429c-8f73-e4c0a272cab7 |
| Associated GPIs | 4220003230G720 |
| GCN Sequence Number | 077749 |
| GCN Sequence Number Description | fluticasone propionate AER BR.ACT 93 MCG NASAL |
| HIC3 | Q7P |
| HIC3 Description | NASAL ANTI-INFLAMMATORY STEROIDS |
| GCN | 43878 |
| HICL Sequence Number | 007873 |
| HICL Sequence Number Description | FLUTICASONE PROPIONATE |
| Brand/Generic | Brand |
| Proprietary Name | XHANCE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | fluticasone propionate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY, METERED |
| Route | NASAL |
| Active Ingredient Strength | 93 |
| Active Ingredient Units | ug/1 |
| Substance Name | FLUTICASONE PROPIONATE |
| Labeler Name | OptiNose US, Inc. |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA209022 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71143-0375-98 (71143037598)
| NDC Package Code | 71143-375-98 |
|---|---|
| Billing NDC | 71143037598 |
| Package | 1 BOTTLE in 1 CARTON (71143-375-98) / 28 SPRAY, METERED in 1 BOTTLE |
| Marketing Start Date | 2019-03-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |